White adipose tissue and liver are important angiotensinogen (AGT) production sites. Until now, plasma AGT was considered to be a reflection of hepatic production. Because plasma AGT concentration has been reported to correlate with blood pressure, and to be associated with body mass index, we investigated whether adipose AGT is released locally and into the blood stream. For this purpose, we have generated transgenic mice either in which adipose AGT is overexpressed or in which AGT expression is restricted to adipose tissue. This was achieved by the use of the aP2 adipocyte-specific promoter driving the expression of rat agt cDNA in both wild-type and hypotensive AGT-deficient mice. Our results show that in both genotypes, targeted expression of AGT in adipose tissue increases fat mass. Mice whose AGT expression is restricted to adipose tissue have AGT circulating in the blood stream, are normotensive, and exhibit restored renal function compared with AGT-deficient mice. Moreover, mice that overexpress adipose AGT have increased levels of circulating AGT, compared with wild-type mice, and are hypertensive. These animal models demonstrate that AGT produced by adipose tissue plays a role in both local adipose tissue development and in the endocrine system, which supports a role of adipose AGT in hypertensive obese patients.
Daily synchronous rhythms of cell division at the tissue or organism level are observed in many species and suggest that the circadian clock and cell cycle oscillators are coupled. For mammals, despite known mechanistic interactions, the effect of such coupling on clock and cell cycle progression, and hence its biological relevance, is not understood. In particular, we do not know how the temporal organization of cell division at the singlecell level produces this daily rhythm at the tissue level. Here we use multispectral imaging of single live cells, computational methods, and mathematical modeling to address this question in proliferating mouse fibroblasts. We show that in unsynchronized cells the cell cycle and circadian clock robustly phase lock each other in a 1:1 fashion so that in an expanding cell population the two oscillators oscillate in a synchronized way with a common frequency. Dexamethasone-induced synchronization reveals additional clock states. As well as the low-period phase-locked state there are distinct coexisting states with a significantly higher period clock. Cells transition to these states after dexamethasone synchronization. The temporal coordination of cell division by phase locking to the clock at a single-cell level has significant implications because disordered circadian function is increasingly being linked to the pathogenesis of many diseases, including cancer.coupled oscillators | oscillations | circadian rhythms | gating
Most living organisms show circadian (ϳ24 h) rhythms in physiology and behavior. These oscillations are generated by endogenous circadian clocks, present in virtually all cells where they control key biological processes. Although circadian gating of mitosis has been reported for many years in some peripheral tissues, the underlying molecular mechanisms have remained poorly understood. Here we show that the cell cycle inhibitor p21 WAF1/CIP1 is rhythmically expressed in mouse peripheral organs. This rhythmic pattern of mRNA and protein expression was recapitulated in vitro in serum-shocked differentiated skeletal muscle cells. p21 WAF1/CIP1 circadian expression is dramatically increased and no longer rhythmic in clock-deficient Bmal1 ؊/؊ knock-out mice. Biochemical and genetic data show that oscillation of p21 WAF1/CIP1 gene transcription is regulated by the antagonistic activities of the orphan nuclear receptors REV-ERB␣/ and ROR␣4/␥, which are core clock regulators. Importantly, p21 WAF1/CIP1 overexpressing Bmal1 ؊/؊ primary hepatocytes exhibit a decreased proliferation rate. This phenotype could be reversed using small interfering RNA-mediated knockdown of p21 WAF1/CIP1 . These data establish a novel molecular link between clock and cell cycle genes and suggest that the G 1 progression phase is a target of the circadian clock during liver cell proliferation.Many physiological and behavioral processes display daynight oscillations in most organisms including mammals. These biological rhythms are controlled by endogenous selfsustained circadian (ϳ24 h) oscillators that operate not only in the central clock located in the suprachiasmatic nuclei of the hypothalamus but also in virtually all peripheral cells. Light is the main synchronizer of the central clock, which in turn coordinates the phases of peripheral oscillators regulating specific physiological outputs. Forward genetics and biochemical approaches have established the molecular basis underlying circadian oscillations in mammalian tissues (1-4). This mechanism involves complex interlocked positive and negative transcriptional/posttranslational feedback loops between the clock genes Clock, Bmal1, Per1, Per2, Cry1, and Cry2 and their protein products. The robustness of the oscillations is ensured by additional regulators such as the REV-ERB␣ (NR1D1) and ROR␣ (NR1F1) orphan nuclear receptors (5, 6). Furthermore, extensive multilevel posttranslational regulation of various clock components has also been shown to play an important role in the molecular clock mechanism (7).There are substantial evidences that progression through the cell cycle occurs at specific times of the day/night cycle, suggesting that a function of the circadian clock system is to control this fundamental process. Notably, after the initial observation almost 40 years ago that cell division of the unicellular algae Euglena was controlled by an endogenous clock (8), numerous studies have shown a circadian variation of the proliferative activity in mammalian tissues such as the epithelia ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.